Advertisement
HIMS vs SKIN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HIMS is a Hold and SKIN is a Hold.
HIMS | SKIN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 29 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | 78 Overvalued | |
PROFIT vs RISK RATING 1..100 | 73 | 100 | |
SMR RATING 1..100 | 97 | 98 | |
PRICE GROWTH RATING 1..100 | 54 | 81 | |
P/E GROWTH RATING 1..100 | 76 | 4 | |
SEASONALITY SCORE 1..100 | 50 | 40 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SKIN's Valuation (78) in the null industry is in the same range as HIMS (81). This means that SKIN’s stock grew similarly to HIMS’s over the last 12 months.
HIMS's Profit vs Risk Rating (73) in the null industry is in the same range as SKIN (100). This means that HIMS’s stock grew similarly to SKIN’s over the last 12 months.
HIMS's SMR Rating (97) in the null industry is in the same range as SKIN (98). This means that HIMS’s stock grew similarly to SKIN’s over the last 12 months.
HIMS's Price Growth Rating (54) in the null industry is in the same range as SKIN (81). This means that HIMS’s stock grew similarly to SKIN’s over the last 12 months.
SKIN's P/E Growth Rating (4) in the null industry is significantly better than the same rating for HIMS (76). This means that SKIN’s stock grew significantly faster than HIMS’s over the last 12 months.
| HIMS | SKIN | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 82% |
| Momentum ODDS (%) | 2 days ago 87% | 2 days ago 85% |
| MACD ODDS (%) | 2 days ago 80% | 2 days ago 86% |
| TrendWeek ODDS (%) | 2 days ago 87% | 2 days ago 89% |
| TrendMonth ODDS (%) | 2 days ago 82% | 2 days ago 88% |
| Advances ODDS (%) | 8 days ago 86% | 19 days ago 79% |
| Declines ODDS (%) | 4 days ago 82% | 4 days ago 88% |
| BollingerBands ODDS (%) | 2 days ago 72% | 2 days ago 80% |
| Aroon ODDS (%) | 2 days ago 79% | 2 days ago 88% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HIMS’s FA Score shows that 0 FA rating(s) are green while SKIN’s FA Score has 1 green FA rating(s).
- HIMS’s FA Score: 0 green, 5 red.
- SKIN’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HIMS’s TA Score shows that 3 TA indicator(s) are bullish while SKIN’s TA Score has 3 bullish TA indicator(s).
- HIMS’s TA Score: 3 bullish, 5 bearish.
- SKIN’s TA Score: 3 bullish, 5 bearish.
Price Growth
HIMS (@Pharmaceuticals: Generic) experienced а +0.07% price change this week, while SKIN (@Household/Personal Care) price change was -4.55% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.71%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +29.84%.
The average weekly price growth across all stocks in the @Household/Personal Care industry was -2.95%. For the same industry, the average monthly price growth was -9.25%, and the average quarterly price growth was +10.83%.
Reported Earning Dates
HIMS is expected to report earnings on Nov 09, 2026.
SKIN is expected to report earnings on Nov 10, 2026.
Industries' Descriptions
@Pharmaceuticals: Generic (-4.71% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
@Household/Personal Care (-2.95% weekly)Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XNTK | 385.41 | 3.22 | +0.84% |
| State Street SPDR NYSE Technology ETF (XNTK) | |||
| EAD | 6.01 | N/A | N/A |
| Allspring Income Opportunities Fund | |||
| TRIO | 65.70 | -0.02 | -0.03% |
| MC Trio Equity Buffered ETF (TRIO) | |||
| TXUG | 27.30 | -0.05 | -0.18% |
| Thornburg International Growth Fund ETF (TXUG) | |||
| FSZ | 77.92 | -0.26 | -0.33% |
| First Trust Switzerland AlphaDEX Fund (FSZ) | |||
HIMS and
Correlation & Price change
A.I.dvisor tells us that HIMS and COTY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and COTY's prices will move in lockstep.
| Ticker / NAME | Correlation To HIMS | 1D Price Change % | ||
|---|---|---|---|---|
| HIMS | 100% | -1.64% | ||
| COTY - HIMS | 31% Poorly correlated | +1.53% | ||
| HROW - HIMS | 25% Poorly correlated | -0.62% | ||
| IRWD - HIMS | 25% Poorly correlated | -5.29% | ||
| EVO - HIMS | 24% Poorly correlated | -3.80% | ||
| IPAR - HIMS | 24% Poorly correlated | +0.80% | ||
More | ||||
SKIN and
Correlation & Price change
A.I.dvisor tells us that SKIN and COTY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SKIN and COTY's prices will move in lockstep.
| Ticker / NAME | Correlation To SKIN | 1D Price Change % | ||
|---|---|---|---|---|
| SKIN | 100% | N/A | ||
| COTY - SKIN | 29% Poorly correlated | +1.53% | ||
| HNST - SKIN | 26% Poorly correlated | -2.14% | ||
| HIMS - SKIN | 23% Poorly correlated | -1.64% | ||
| NUS - SKIN | 22% Poorly correlated | +0.44% | ||
| ACU - SKIN | 22% Poorly correlated | -0.43% | ||
More | ||||